Ventyx Biosciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ventyx Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Ventyx Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.77M, a 26.7% decline year-over-year.
  • Ventyx Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $26.5M, a 13% increase year-over-year.
  • Ventyx Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $28.6M, a 72.5% increase from 2022.
  • Ventyx Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16.6M, a 507% increase from 2021.
  • Ventyx Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.73M, a 5967% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $28.6M +$12M +72.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $16.6M +$13.8M +507% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $2.73M +$2.69M +5967% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $45K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.